[The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE